Jaguar Health (JAGX) Notes Payables (2014 - 2026)
Jaguar Health (JAGX) posted quarterly Notes Payables of $22.1 million for Q1 2026, up 18.46% year-over-year from $18.6 million in Q1 2025, and down 19.54% quarter-over-quarter from $27.4 million in Q4 2025.
Jaguar Health (JAGX) Notes Payables (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported Notes Payables for 13 consecutive years, with $22.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Notes Payables rose 18.46% year-over-year to $22.1 million; the TTM figure through Mar 2026 stood at $22.1 million (up 18.46% YoY), while the FY2025 annual figure was $27.4 million, up 127.94% from the prior year.
- Notes Payables declined to $22.1 million in Q1 2026 per JAGX's latest filing, from $27.4 million in the prior quarter.
- Across five years, Notes Payables topped out at $27.4 million in Q4 2025 and bottomed at $3.5 million in Q3 2023.
- Historically, Notes Payables has averaged $13.8 million across 5 years, with a median of $12.0 million in 2024.
- Annual changes were most pronounced in 2022 — Notes Payables jumped 594.59% — and 2023, when it plunged 70.1%.
- Jaguar Health's Notes Payables stood at $15.9 million in 2022, then plunged by 69.36% to $4.9 million in 2023, then surged by 147.34% to $12.0 million in 2024, then surged by 127.94% to $27.4 million in 2025, then decreased by 19.54% to $22.1 million in 2026.
- Business Quant data shows JAGX's Notes Payables at $22.1 million in Q1 2026, $27.4 million in Q4 2025, and $23.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.81 Bn | 131.96 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.56 Bn | 78.56 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.72 Bn | 60.53 Bn | 1.37 Bn |
| 4 | Moderna | 58.75 Bn | 53.61 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.76 Bn | 28.45 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.59 Bn | 10.19 Bn | 668.28 Mn |
| 8 | Insmed | 27.63 Bn | 26.47 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.24 Bn | 26.40 Bn | - |
| 10 | Jaguar Health | 457,761.84 | -9.61 Mn | 19.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.08 Mn |
| Dec 31, 2025 | 27.44 Mn |
| Sep 30, 2025 | 23.11 Mn |
| Jun 30, 2025 | 18.57 Mn |
| Mar 31, 2025 | 18.64 Mn |
| Dec 31, 2024 | 12.04 Mn |
| Sep 30, 2024 | 11.49 Mn |
| Jun 30, 2024 | 11.12 Mn |
| Mar 31, 2024 | 10.39 Mn |
| Dec 31, 2023 | 4.87 Mn |
| Sep 30, 2023 | 3.51 Mn |
| Jun 30, 2023 | 13.81 Mn |
| Mar 31, 2023 | 15.62 Mn |
| Dec 31, 2022 | 15.88 Mn |
| Sep 30, 2022 | 11.74 Mn |
| Jun 30, 2022 | 7.95 Mn |
| Mar 31, 2022 | 6.89 Mn |
| Dec 31, 2021 | 3.18 Mn |
| Sep 30, 2021 | 1.78 Mn |
| Jun 30, 2021 | 1.15 Mn |